EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identifying CDCA4 as a Radiotherapy Resistance-Associated Gene in Colorectal Cancer by an Integrated Bioinformatics Analysis Approach

Lin Chen, Yawei Gao, Zhiqing Hu, Jingwen Si, Yuchao Zhang, Qingping Cai

Genes · 2025

DOI: 10.3390/genes16060696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Lin Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Department of General Surgery, Shanghai East Hospital, School of Life Sciences and Technology, Tongji Univers…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cell Cycle Proteins, Radiation Tolerance, Nuclear Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Fund for Health Science and Technology of Social Development Shanghai Pudong New Area.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) remains one of the most prevalent and fatal malignancies globally, with radiotherapy playing a crucial role in the treatment of locally advanced rectal cancer (LARC). However, the efficacy of radiotherapy is limited by significant resistance, with only a small proportion of patients achieving a pathologic complete response (PCR) to neoadjuvant chemoradiotherapy (nCRT). This study aims to uncover the genetic and molecular factors contributing to radiotherapy resistance in CRC through an integrated analysis of germline mutations, transcriptomic data, and immune microenvironment characteristics.

Methods

Whole-exome sequencing (WES) was performed on tumor samples from 12 LARC patients. Transcriptomic data from the TCGA-READ and GSE150082 (LARC with chemoradiotherapy) cohorts were integrated with WES findings. The independent cohort GSE190826 (neoadjuvant therapy in rectal cancer) dataset was utilized to validate the WES data. Single-cell RNA sequencing (scRNA-seq) analysis of GSE132465 (primary CRC) resolved cellular heterogeneity. A random forest algorithm was employed to develop a predictive gene signature.

Results

Our findings reveal a mutational landscape associated with radiotherapy resistance, identifying specific germline mutations linked to treatment outcomes. Differential gene expression analysis highlighted pathways involved in DNA replication, DNA repair, and immune regulation, with a focus on the tumor immune microenvironment (TIME). A gene signature, including CDCA4, FANCA, PBRM1, RPL13, and C12orf43, was developed to predict radiotherapy response. Notably, CDCA4 expression was significantly associated with tumor mutation burden (TMB) and microsatellite instability (MSI), and it plays a crucial role in regulating B cell infiltration in the tumor microenvironment.

Conclusions

Our study provides novel insights into the molecular mechanisms of radiotherapy resistance in CRC and proposes CDCA4 and B cell-related immune features as potential biomarkers for patient stratification and personalized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCell Cycle ProteinsRadiation ToleranceNuclear ProteinsHumansComputational BiologyTumor MicroenvironmentMaleFemaleExome SequencingGene Expression Regulation, NeoplasticBiomarkers, TumorMutationMiddle AgedTranscriptome

Stichwörter der Autor:innen

B cell infiltrationCDCA4colorectal cancerneoadjuvant chemoradiotherapyradiotherapy resistancewhole-exome sequencing

Substanzen

Cell Cycle ProteinsNuclear ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Department of General Surgery, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200120, China.
  • Department of Gastrointestinal Surgery, Department of General Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.
  • Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai 200120, China.
  • CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai 201203, China.

Förderung

  • Special Fund for Health Science and Technology of Social Development Shanghai Pudong New Area

Zitieren

APA

Chen, L., Gao, Y., Hu, Z., Si, J., Zhang, Y., & Cai, Q. (2025). Identifying CDCA4 as a Radiotherapy Resistance-Associated Gene in Colorectal Cancer by an Integrated Bioinformatics Analysis Approach. Genes. https://doi.org/10.3390/genes16060696

Vancouver

Chen L, Gao Y, Hu Z, Si J, Zhang Y, Cai Q. Identifying CDCA4 as a Radiotherapy Resistance-Associated Gene in Colorectal Cancer by an Integrated Bioinformatics Analysis Approach. Genes. 2025. doi:10.3390/genes16060696

BibTeX
@article{Chen2025,
  author = {Chen, Lin and Gao, Yawei and Hu, Zhiqing and Si, Jingwen and Zhang, Yuchao and Cai, Qingping},
  title = {Identifying CDCA4 as a Radiotherapy Resistance-Associated Gene in Colorectal Cancer by an Integrated Bioinformatics Analysis Approach},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16060696}
}
Kostenlos starten →